Last reviewed · How we verify

HD Fluzone Vaccine

Insight Therapeutics, LLC · FDA-approved active Biologic Quality 2/100

HD Fluzone Vaccine is a Biologic drug developed by Insight Therapeutics, LLC. It is currently FDA-approved. Also known as: Fluzone High Dose influenza vaccine.

At a glance

Generic nameHD Fluzone Vaccine
Also known asFluzone High Dose influenza vaccine
SponsorInsight Therapeutics, LLC
ModalityBiologic
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about HD Fluzone Vaccine

What is HD Fluzone Vaccine?

HD Fluzone Vaccine is a Biologic drug developed by Insight Therapeutics, LLC.

Who makes HD Fluzone Vaccine?

HD Fluzone Vaccine is developed and marketed by Insight Therapeutics, LLC (see full Insight Therapeutics, LLC pipeline at /company/insight-therapeutics-llc).

Is HD Fluzone Vaccine also known as anything else?

HD Fluzone Vaccine is also known as Fluzone High Dose influenza vaccine.

What development phase is HD Fluzone Vaccine in?

HD Fluzone Vaccine is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing